Israel to start vaccinations against new Omicron substrains


Jerusalem, Sep 22 (IANS): Israel will soon start vaccinations against new Omicron substrains of Covid-19, the Health Ministry has announced in a statement.

The ministry on Thursday recommended that the entire population be vaccinated against the new subvariants, especially patients suffering from immunosuppression, Xinhua news agency reported.

The ministry noted that Israel sees a moderate increase in the number of hospitalized patients, most are mild cases.

Meanwhile, there is also a small increase in the number of patients in serious condition and a marginal rise in mortality.

The new round of vaccinations will first start with people aged 12 and over and children who are at risk.

Other populations will be eligible to be vaccinated in the second stage after the country receives an additional stock of vaccines, the statement noted.

According to the ministry's latest update earlier this week, Israel has 1,167 reported active Covid-19 patients, 53 of whom are in serious condition.

Since the outbreak of the pandemic in Israel in 2020, 12,670 people have died from the virus in the country.

 

  

Top Stories


Leave a Comment

Title: Israel to start vaccinations against new Omicron substrains



You have 2000 characters left.

Disclaimer:

Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Daijiworld.com will not be responsible for any defamatory message posted under this article.

Please note that sending false messages to insult, defame, intimidate, mislead or deceive people or to intentionally cause public disorder is punishable under law. It is obligatory on Daijiworld to provide the IP address and other details of senders of such comments, to the authority concerned upon request.

Hence, sending offensive comments using daijiworld will be purely at your own risk, and in no way will Daijiworld.com be held responsible.